Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-05-18 Purchase | 2021-05-20 4:32 pm | Marker Therapeutics Inc. | MRKR | Wasserman Frederick Gerald Director | 10,000 | $2.4098 | $24,098 | 52,565 (Direct) | View |
| 2021-03-16 Purchase | 2021-03-18 5:18 pm | Marker Therapeutics Inc. | MRKR | Walker Paul Edward 10% Owner | 5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) | View |
| 2021-03-16 Purchase | 2021-03-18 5:17 pm | Marker Therapeutics Inc. | MRKR | Sonsini Peter W. 10% Owner | 5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) | View |
| 2021-03-16 Purchase | 2021-03-18 5:17 pm | Marker Therapeutics Inc. | MRKR | SANDELL SCOTT D 10% Owner | 5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) | View |
| 2021-03-16 Purchase | 2021-03-18 5:16 pm | Marker Therapeutics Inc. | MRKR | MAKOWER JOSHUA 10% Owner | 5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) | View |
| 2021-03-16 Purchase | 2021-03-18 5:15 pm | Marker Therapeutics Inc. | MRKR | Makhzoumi Mohamad 10% Owner | 5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) | View |
| 2021-03-16 Purchase | 2021-03-18 5:14 pm | Marker Therapeutics Inc. | MRKR | Florence Anthony A. Jr. 10% Owner | 5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) | View |
| 2021-03-16 Purchase | 2021-03-18 5:12 pm | Marker Therapeutics Inc. | MRKR | Chang Carmen 10% Owner | 5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) | View |
| 2021-03-16 Purchase | 2021-03-18 5:11 pm | Marker Therapeutics Inc. | MRKR | Behbahani Ali 10% Owner | 5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) | View |
| 2021-03-16 Purchase | 2021-03-18 5:09 pm | Marker Therapeutics Inc. | MRKR | BASKETT FOREST 10% Owner | 5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Indirect) | View |
| 2021-03-16 Purchase | 2021-03-18 5:08 pm | Marker Therapeutics Inc. | MRKR | New Enterprise Associates 16 L.P. NEA Partners 16 L.P. NEA 16 GP LLC 10% Owner | 5,714,285 | $1.75 | $9,999,999 | 10,714,285 (Direct) | View |
| 2021-03-16 Purchase | 2021-03-18 4:39 pm | Marker Therapeutics Inc. | MRKR | Wilson John Robert Director | 1,714,285 | $1.75 | $2,999,999 | 7,799,350 (Direct) | View |
| 2021-03-16 Purchase | 2021-03-18 4:38 pm | Marker Therapeutics Inc. | MRKR | Vera Juan Chief Development Officer | 571,428 | $1.75 | $999,999 | 2,564,487 (Direct) | View |
| 2021-03-16 Purchase | 2021-03-18 4:36 pm | Marker Therapeutics Inc. | MRKR | Hoang Peter L. CEO | 142,857 | $1.75 | $250,000 | 332,568 (Direct) | View |
| 2021-03-16 Purchase | 2021-03-18 4:35 pm | Marker Therapeutics Inc. | MRKR | ELMS STEVE Director | 1,142,857 | $1.75 | $2,000,000 | 3,159,879 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-05-24 Option Award | 2022-05-26 4:12 pm | N/A 2032-05-23 | Marker Therapeutics Inc. | MRKR | Wilson John Robert Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 4:10 pm | N/A 2032-05-23 | Marker Therapeutics Inc. | MRKR | Laskow-Pooley David Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 4:10 pm | N/A 2032-05-23 | Marker Therapeutics Inc. | MRKR | Knobil Katharine Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 4:09 pm | N/A 2032-05-23 | Marker Therapeutics Inc. | MRKR | ELMS STEVE Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-05-24 Option Award | 2022-05-26 4:08 pm | N/A 2032-05-23 | Marker Therapeutics Inc. | MRKR | Eansor Norman David Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-03-24 Option Award | 2022-03-28 9:06 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Hoang Peter L. CEO | 199,094 | $0 | 483,286 (Direct) | View |
| 2022-03-24 Tax Withholding | 2022-03-28 9:06 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Hoang Peter L. CEO | 48,376 | $0.4848 | 483,286 (Direct) | View |
| 2022-03-24 Option Award | 2022-03-28 9:04 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Vera Juan COO | 140,823 | $0 | 2,671,845 (Direct) | View |
| 2022-03-24 Tax Withholding | 2022-03-28 9:04 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Vera Juan COO | 33,465 | $0.4848 | 2,671,845 (Direct) | View |
| 2022-03-24 Option Award | 2022-03-28 9:03 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Kim Anthony H. CFO | 150,512 | $0 | 114,436 (Direct) | View |
| 2022-03-24 Tax Withholding | 2022-03-28 9:03 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Kim Anthony H. CFO | 36,076 | $0.4848 | 114,436 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 5:14 pm | N/A 2032-02-17 | Marker Therapeutics Inc. | MRKR | Hoang Peter L. CEO | 430,000 | $0 | 430,000 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 5:12 pm | N/A 2032-02-17 | Marker Therapeutics Inc. | MRKR | Vera Juan COO | 160,000 | $0 | 160,000 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 5:10 pm | N/A 2032-02-17 | Marker Therapeutics Inc. | MRKR | Szymanska Anna VP | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 5:09 pm | N/A 2032-02-17 | Marker Therapeutics Inc. | MRKR | Loiacono Michael CAO | 140,000 | $0 | 140,000 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 5:07 pm | N/A 2032-02-17 | Marker Therapeutics Inc. | MRKR | Koneru Mythili Chief Medical Officer | 160,000 | $0 | 160,000 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 5:06 pm | N/A 2032-02-17 | Marker Therapeutics Inc. | MRKR | Kim Anthony H. CFO | 160,000 | $0 | 160,000 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 5:04 pm | N/A 2032-02-17 | Marker Therapeutics Inc. | MRKR | Hoang Tsvetelina P VP | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 5:02 pm | N/A 2032-02-17 | Marker Therapeutics Inc. | MRKR | Garrett Gerald VP | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 5:01 pm | N/A 2032-02-17 | Marker Therapeutics Inc. | MRKR | Agopyan Nadia VP | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-09 5:20 pm | N/A 2031-12-07 | Marker Therapeutics Inc. | MRKR | Knobil Katharine Director | 125,000 | $0 | 125,000 (Direct) | View |
| 2021-12-08 Ownership | 2021-12-09 5:18 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Knobil Katharine Director | 0 | $0 | 1,500 (Indirect) | View |
| 2021-06-08 Option Award | 2021-06-10 6:57 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Wasserman Frederick Gerald Director | 12,658 | $0 | 65,223 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 6:56 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Laskow-Pooley David Director | 12,658 | $0 | 55,223 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 6:55 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | ELMS STEVE Director | 12,658 | $0 | 3,172,537 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 6:54 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Eansor Norman David Director | 12,658 | $0 | 36,940 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 6:53 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | Wilson John Robert Director | 12,658 | $0 | 7,812,008 (Direct) | View |